Diagnostics company Biolidics has seen its share price jump 35% since its rapid test kit for Covid-19 has been accepted for sale in a number of countries. Earlier this week,…
Diagnostics company Biolidics has seen its share price jump 35% since its rapid test kit for Covid-19 has been accepted for sale in a number of countries. Earlier this week,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


